Name:
Manganese(II) chloride tetrahydrate
Synonym:
Manganous chloride tetrahydrate; Manganese dichloride tetrahydrate
CAS:
7773-01-5
Section 1 - Chemical Product
MSDS Name:Manganese(II) chloride tetrahydrate
Synonym:Manganous chloride tetrahydrate; Manganese dichloride tetrahydrate
Synonym:Manganous chloride tetrahydrate; Manganese dichloride tetrahydrate
Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
| CAS# | Chemical Name | emsds | EINECS# |
| 7773-01-5 | Manganese(II) chloride tetrahydrate | >98 | unlisted |
| Hazard Symbols: XN Risk Phrases: 22 |
Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful if swallowed.Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
Harmful if swallowed. May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May cause central nervous system effects and/or neurological effects. In high doses, manganese may increase anemia by interfering with iron absorption.
Inhalation:
May cause respiratory tract irritation. The lowest exposure concentration of manganese at which early effects on the CNS and the lungs may occur is still unknown. However, once neurological signs are present, they tend to continue and worsen after exposure ends.
Chronic:
Chronic inhalation or ingestion may result in manganism characterized by neurological symptoms such as headache, apathy, and weakness of the legs, followed by psychosis and neurological symptoms similar to those of Parkinsons disease. May impair fertility. Other chronic effects from inhaling high amounts of manganese include an increased incidence of cough and bronchitis and susceptibility to infectious lung disease.
Harmful if swallowed.Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
Harmful if swallowed. May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May cause central nervous system effects and/or neurological effects. In high doses, manganese may increase anemia by interfering with iron absorption.
Inhalation:
May cause respiratory tract irritation. The lowest exposure concentration of manganese at which early effects on the CNS and the lungs may occur is still unknown. However, once neurological signs are present, they tend to continue and worsen after exposure ends.
Chronic:
Chronic inhalation or ingestion may result in manganism characterized by neurological symptoms such as headache, apathy, and weakness of the legs, followed by psychosis and neurological symptoms similar to those of Parkinsons disease. May impair fertility. Other chronic effects from inhaling high amounts of manganese include an increased incidence of cough and bronchitis and susceptibility to infectious lung disease.
Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get medical aid if irritation develops or persists. Wash clothing before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively. Persons with impaired respiratory function or anemia may be at increased risk to the hazards associated with this substance.
Skin:
Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get medical aid if irritation develops or persists. Wash clothing before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively. Persons with impaired respiratory function or anemia may be at increased risk to the hazards associated with this substance.
Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Substance is noncombustible.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire.
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Substance is noncombustible.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire.
Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Avoid generating dusty conditions. Provide ventilation.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Avoid generating dusty conditions. Provide ventilation.
Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid breathing dust.
Storage:
Keep container closed when not in use. Store protected from moisture.
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid breathing dust.
Storage:
Keep container closed when not in use. Store protected from moisture.
Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels below recommended exposure limits. Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower.
Exposure Limits CAS# 7773-01-5: United Kingdom, WEL - TWA: (listed as manganese, inorganic compounds): 0.5 mg/m3 TWA United Kingdom, WEL - STEL: (listed as manganese, inorganic compounds): 1.5 mg/m3 STEL United States OSHA: 5 mg/m3 Ceiling (as Mn) (listed under Mangan compounds, n.o.s.).
Belgium - TWA: (listed as manganese compounds, n.o.s.): 0.2 mg/m3 (as Mn) Japan: (listed as manganese compounds, n.o.s.): 0.3 mg/m3 OEL (ex organic compounds, as Mn) Malaysia: (listed as manganese, inorganic compounds): 0.2 mg/m3 T (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 3 mg/m3 STE (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 1 mg/m3 MAC Mn) Spain: (listed as manganese, inorganic compounds): 0.2 mg/m3 VLA- (as Mn) CAS# 13446-34-9: United Kingdom, WEL - TWA: (listed as manganese, inorganic compounds): 0.5 mg/m3 TWA United Kingdom, WEL - STEL: (listed as manganese, inorganic compounds): 1.5 mg/m3 STEL United States OSHA: 5 mg/m3 Ceiling (as Mn) (listed under Mangan compounds, n.o.s.).
Belgium - TWA: (listed as manganese compounds, n.o.s.): 0.2 mg/m3 (as Mn) Japan: (listed as manganese compounds, n.o.s.): 0.3 mg/m3 OEL (ex organic compounds, as Mn) Malaysia: (listed as manganese, inorganic compounds): 0.2 mg/m3 T (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 3 mg/m3 STE (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 1 mg/m3 MAC Mn) Spain: (listed as manganese, inorganic compounds): 0.2 mg/m3 VLA- (as Mn) Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHAs 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.
Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels below recommended exposure limits. Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower.
Exposure Limits CAS# 7773-01-5: United Kingdom, WEL - TWA: (listed as manganese, inorganic compounds): 0.5 mg/m3 TWA United Kingdom, WEL - STEL: (listed as manganese, inorganic compounds): 1.5 mg/m3 STEL United States OSHA: 5 mg/m3 Ceiling (as Mn) (listed under Mangan compounds, n.o.s.).
Belgium - TWA: (listed as manganese compounds, n.o.s.): 0.2 mg/m3 (as Mn) Japan: (listed as manganese compounds, n.o.s.): 0.3 mg/m3 OEL (ex organic compounds, as Mn) Malaysia: (listed as manganese, inorganic compounds): 0.2 mg/m3 T (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 3 mg/m3 STE (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 1 mg/m3 MAC Mn) Spain: (listed as manganese, inorganic compounds): 0.2 mg/m3 VLA- (as Mn) CAS# 13446-34-9: United Kingdom, WEL - TWA: (listed as manganese, inorganic compounds): 0.5 mg/m3 TWA United Kingdom, WEL - STEL: (listed as manganese, inorganic compounds): 1.5 mg/m3 STEL United States OSHA: 5 mg/m3 Ceiling (as Mn) (listed under Mangan compounds, n.o.s.).
Belgium - TWA: (listed as manganese compounds, n.o.s.): 0.2 mg/m3 (as Mn) Japan: (listed as manganese compounds, n.o.s.): 0.3 mg/m3 OEL (ex organic compounds, as Mn) Malaysia: (listed as manganese, inorganic compounds): 0.2 mg/m3 T (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 3 mg/m3 STE (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 1 mg/m3 MAC Mn) Spain: (listed as manganese, inorganic compounds): 0.2 mg/m3 VLA- (as Mn) Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHAs 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.
Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Solid
Color: reddish
Odor: none reported
pH: 5.5 (0.2M aq soln)
Vapor Pressure: Not applicable.
Viscosity: Not applicable.
Boiling Point: Not available.
Freezing/Melting Point: 58 deg C
Autoignition Temperature: Not available.
Flash Point: Non-flammable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Freely Soluble.
Specific Gravity/Density: 2.01 g/cm3
Molecular Formula: MnCl2.4H2O
Molecular Weight: 197.91
Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures. Deliquescent (tending to absorb atmospheric water vapor and become liquid).
Conditions to Avoid:
Dust generation, excess heat, exposure to moist air or water.
Incompatibilities with Other Materials:
Zinc, potassium, sodium.
Hazardous Decomposition Products:
Hydrogen chloride, irritating and toxic fumes and gases, oxides of manganese.
Hazardous Polymerization: Has not been reported.
Stable under normal temperatures and pressures. Deliquescent (tending to absorb atmospheric water vapor and become liquid).
Conditions to Avoid:
Dust generation, excess heat, exposure to moist air or water.
Incompatibilities with Other Materials:
Zinc, potassium, sodium.
Hazardous Decomposition Products:
Hydrogen chloride, irritating and toxic fumes and gases, oxides of manganese.
Hazardous Polymerization: Has not been reported.
Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 7773-01-5: OO9625000 CAS# 13446-34-9: OO9650000 LD50/LC50:
CAS# 7773-01-5: Oral, mouse: LD50 = 1031 mg/kg; Oral, mouse: LD50 = 450 mg/kg; Oral, rat: LD50 = 250 mg/kg.
CAS# 13446-34-9: Oral, rat: LD50 = 1484 mg/kg.
Carcinogenicity:
Manganese(II) chloride anhydrous - Not listed by ACGIH, IARC, or NTP.
Manganese(II) chloride tetrahydrate - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
CAS# 7773-01-5: OO9625000 CAS# 13446-34-9: OO9650000 LD50/LC50:
CAS# 7773-01-5: Oral, mouse: LD50 = 1031 mg/kg; Oral, mouse: LD50 = 450 mg/kg; Oral, rat: LD50 = 250 mg/kg.
CAS# 13446-34-9: Oral, rat: LD50 = 1484 mg/kg.
Carcinogenicity:
Manganese(II) chloride anhydrous - Not listed by ACGIH, IARC, or NTP.
Manganese(II) chloride tetrahydrate - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
Section 12 - ECOLOGICAL INFORMATION
Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.
Section 14 - TRANSPORT INFORMATION
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
Section 15 - REGULATORY INFORMATION
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 7773-01-5: 1
CAS# 13446-34-9: No information available.
Canada
CAS# 7773-01-5 is listed on Canadas DSL List.
CAS# 7773-01-5 is listed on Canadas Ingredient Disclosure List.
CAS# 13446-34-9 is not listed on Canadas Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7773-01-5 is listed on the TSCA inventory.
CAS# 13446-34-9 is not on the TSCA Inventory because it is a hydrate.
It is considered to be listed if the CAS number for the anhydrous form
is on the inventory (40CFR720.3(u)(2)).
